tslp protein Search Results


94
R&D Systems recombinant human tslp
The inhibitory effects of isolated compounds 1 – 3 on thymic stromal lymphopoietin <t> (TSLP)/TSLP </t> receptor (TSLPR) interaction by ELISA.
Recombinant Human Tslp, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tslp+protein/Recombinant+Human+TSLP+Protein/pmc08398558-58-8-14
Average 94 stars, based on 1 article reviews
recombinant human tslp - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

93
Miltenyi Biotec rea181 miltenyi biotech 130 100 552 cd90 apc cy7
The inhibitory effects of isolated compounds 1 – 3 on thymic stromal lymphopoietin <t> (TSLP)/TSLP </t> receptor (TSLPR) interaction by ELISA.
Rea181 Miltenyi Biotech 130 100 552 Cd90 Apc Cy7, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tslp+protein/CD51+Antibody%2C+anti-human%2C+REAfinity/pmc11237034__41467_2024_50054_MOESM1_ESM-176-18-19
Average 93 stars, based on 1 article reviews
rea181 miltenyi biotech 130 100 552 cd90 apc cy7 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

95
Miltenyi Biotec cd163 human antibody

Cd163 Human Antibody, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tslp+protein/CD163+Antibody%2C+anti-human/pmc11088341-137-0-6
Average 95 stars, based on 1 article reviews
cd163 human antibody - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier

94
R&D Systems recombinant mouse tslp
Inflammation was assessed in DSS-treated <t>Tslp-/-</t> mice by (A) macroscopic disease, (B) colon length, (C) serum SAA concentration, (D&E) histological damage, (F) weight loss, and (G) survival. Graphs indicate: control (open bars), DSS (solid bars), mean ± SD, n=10-15 mice/group, scale bar=50μm, *P<0.05, ANOVA.
Recombinant Mouse Tslp, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tslp+protein/Recombinant+Mouse+TSLP+Protein/pmc03169330-381-4-7
Average 94 stars, based on 1 article reviews
recombinant mouse tslp - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

94
R&D Systems recombinant mouse tslp rmtslp
Figure 1. CRLF2 mRNA and <t>TSLP</t> protein are elevated in patient endometriotic lesions compared with control endometrial samples. RT-qPCR was run with RNA extracted from control endometria (n ¼ 7), patient eutopic endometria (n ¼ 5), and endometriotic lesions (n ¼ 8). The expression of (A) TSLP, (B) CRLF2, and (C) IL-7R was quantified relative to the GAPDH reference gene. A TMA with (D) control endometrial tissue (n ¼ 15) and matched (E) patient (n ¼ 15) eutopic endometria and (F) endometriotic lesions was stained with anti-TSLP Ab. TSLP-positive (G) stromal and (H) epithelial area was calculated as a fraction of total stromal and epithelial area, respectively, using HALO AI. Magnification provided at 8×. Scale bars ¼ 100 μm. A 1-way analysis of variance with Tukey post hoc test was used to assess statistical significance. P < 0.05, P < 0.01.
Recombinant Mouse Tslp Rmtslp, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tslp+protein/Recombinant+Mouse+TSLP+Protein/pm40073108-55-13-18
Average 94 stars, based on 1 article reviews
recombinant mouse tslp rmtslp - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

96
Miltenyi Biotec texmacs gmp medium
Figure 1. CRLF2 mRNA and <t>TSLP</t> protein are elevated in patient endometriotic lesions compared with control endometrial samples. RT-qPCR was run with RNA extracted from control endometria (n ¼ 7), patient eutopic endometria (n ¼ 5), and endometriotic lesions (n ¼ 8). The expression of (A) TSLP, (B) CRLF2, and (C) IL-7R was quantified relative to the GAPDH reference gene. A TMA with (D) control endometrial tissue (n ¼ 15) and matched (E) patient (n ¼ 15) eutopic endometria and (F) endometriotic lesions was stained with anti-TSLP Ab. TSLP-positive (G) stromal and (H) epithelial area was calculated as a fraction of total stromal and epithelial area, respectively, using HALO AI. Magnification provided at 8×. Scale bars ¼ 100 μm. A 1-way analysis of variance with Tukey post hoc test was used to assess statistical significance. P < 0.05, P < 0.01.
Texmacs Gmp Medium, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tslp+protein/TexMACS+GMP+Medium/pm33020647__41591_2020_1081_MOESM1_ESM-53-4-7
Average 96 stars, based on 1 article reviews
texmacs gmp medium - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

90
R&D Systems tslp
Figure 1. CRLF2 mRNA and <t>TSLP</t> protein are elevated in patient endometriotic lesions compared with control endometrial samples. RT-qPCR was run with RNA extracted from control endometria (n ¼ 7), patient eutopic endometria (n ¼ 5), and endometriotic lesions (n ¼ 8). The expression of (A) TSLP, (B) CRLF2, and (C) IL-7R was quantified relative to the GAPDH reference gene. A TMA with (D) control endometrial tissue (n ¼ 15) and matched (E) patient (n ¼ 15) eutopic endometria and (F) endometriotic lesions was stained with anti-TSLP Ab. TSLP-positive (G) stromal and (H) epithelial area was calculated as a fraction of total stromal and epithelial area, respectively, using HALO AI. Magnification provided at 8×. Scale bars ¼ 100 μm. A 1-way analysis of variance with Tukey post hoc test was used to assess statistical significance. P < 0.05, P < 0.01.
Tslp, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tslp+protein/Recombinant+Mouse+TSLP+Protein%2C+CF/pm21677670-160-10-12
Average 90 stars, based on 1 article reviews
tslp - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

96
Miltenyi Biotec clinimacs cd34 reagent system
Figure 1. CRLF2 mRNA and <t>TSLP</t> protein are elevated in patient endometriotic lesions compared with control endometrial samples. RT-qPCR was run with RNA extracted from control endometria (n ¼ 7), patient eutopic endometria (n ¼ 5), and endometriotic lesions (n ¼ 8). The expression of (A) TSLP, (B) CRLF2, and (C) IL-7R was quantified relative to the GAPDH reference gene. A TMA with (D) control endometrial tissue (n ¼ 15) and matched (E) patient (n ¼ 15) eutopic endometria and (F) endometriotic lesions was stained with anti-TSLP Ab. TSLP-positive (G) stromal and (H) epithelial area was calculated as a fraction of total stromal and epithelial area, respectively, using HALO AI. Magnification provided at 8×. Scale bars ¼ 100 μm. A 1-way analysis of variance with Tukey post hoc test was used to assess statistical significance. P < 0.05, P < 0.01.
Clinimacs Cd34 Reagent System, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tslp+protein/CliniMACS+CD34+Reagent/us11285211-357-14-18
Average 96 stars, based on 1 article reviews
clinimacs cd34 reagent system - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

90
R&D Systems tslp r d systems
Figure 1. CRLF2 mRNA and <t>TSLP</t> protein are elevated in patient endometriotic lesions compared with control endometrial samples. RT-qPCR was run with RNA extracted from control endometria (n ¼ 7), patient eutopic endometria (n ¼ 5), and endometriotic lesions (n ¼ 8). The expression of (A) TSLP, (B) CRLF2, and (C) IL-7R was quantified relative to the GAPDH reference gene. A TMA with (D) control endometrial tissue (n ¼ 15) and matched (E) patient (n ¼ 15) eutopic endometria and (F) endometriotic lesions was stained with anti-TSLP Ab. TSLP-positive (G) stromal and (H) epithelial area was calculated as a fraction of total stromal and epithelial area, respectively, using HALO AI. Magnification provided at 8×. Scale bars ¼ 100 μm. A 1-way analysis of variance with Tukey post hoc test was used to assess statistical significance. P < 0.05, P < 0.01.
Tslp R D Systems, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tslp+protein/Recombinant+Mouse+TSLP+Protein%2C+CF/pm32268121-234-54-55
Average 90 stars, based on 1 article reviews
tslp r d systems - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

93
Miltenyi Biotec bcma scfv specific recognition reagent
Figure 1. CRLF2 mRNA and <t>TSLP</t> protein are elevated in patient endometriotic lesions compared with control endometrial samples. RT-qPCR was run with RNA extracted from control endometria (n ¼ 7), patient eutopic endometria (n ¼ 5), and endometriotic lesions (n ¼ 8). The expression of (A) TSLP, (B) CRLF2, and (C) IL-7R was quantified relative to the GAPDH reference gene. A TMA with (D) control endometrial tissue (n ¼ 15) and matched (E) patient (n ¼ 15) eutopic endometria and (F) endometriotic lesions was stained with anti-TSLP Ab. TSLP-positive (G) stromal and (H) epithelial area was calculated as a fraction of total stromal and epithelial area, respectively, using HALO AI. Magnification provided at 8×. Scale bars ¼ 100 μm. A 1-way analysis of variance with Tukey post hoc test was used to assess statistical significance. P < 0.05, P < 0.01.
Bcma Scfv Specific Recognition Reagent, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tslp+protein/BCMA+CAR+Detection+Reagent%2C+human/us12419955-180-31-35
Average 93 stars, based on 1 article reviews
bcma scfv specific recognition reagent - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

93
R&D Systems human tslp
Figure 1. CRLF2 mRNA and <t>TSLP</t> protein are elevated in patient endometriotic lesions compared with control endometrial samples. RT-qPCR was run with RNA extracted from control endometria (n ¼ 7), patient eutopic endometria (n ¼ 5), and endometriotic lesions (n ¼ 8). The expression of (A) TSLP, (B) CRLF2, and (C) IL-7R was quantified relative to the GAPDH reference gene. A TMA with (D) control endometrial tissue (n ¼ 15) and matched (E) patient (n ¼ 15) eutopic endometria and (F) endometriotic lesions was stained with anti-TSLP Ab. TSLP-positive (G) stromal and (H) epithelial area was calculated as a fraction of total stromal and epithelial area, respectively, using HALO AI. Magnification provided at 8×. Scale bars ¼ 100 μm. A 1-way analysis of variance with Tukey post hoc test was used to assess statistical significance. P < 0.05, P < 0.01.
Human Tslp, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tslp+protein/Recombinant+Human+TSLP+Protein%2C+CF/pmc03412346-108-7-11
Average 93 stars, based on 1 article reviews
human tslp - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

Image Search Results


The inhibitory effects of isolated compounds 1 – 3 on thymic stromal lymphopoietin  (TSLP)/TSLP  receptor (TSLPR) interaction by ELISA.

Journal: Molecules

Article Title: Lignans from Machilus thunbergii as Thymic Stromal Lymphopoietin Inhibitors

doi: 10.3390/molecules26164804

Figure Lengend Snippet: The inhibitory effects of isolated compounds 1 – 3 on thymic stromal lymphopoietin (TSLP)/TSLP receptor (TSLPR) interaction by ELISA.

Article Snippet: For the pSTAT5 assay measuring TSLP inhibitory activity, recombinant human TSLP was purchased from R&D Systems (Minneapolis, MN, USA) and BD Cytofix/Cytoperm and Alexa Fluor 647 mouse anti-STAT5 (pY694) were purchased from BD Biosciences (San Diego, CA, USA).

Techniques: Isolation, Enzyme-linked Immunosorbent Assay, Inhibition, Control

Molecular docking results of isolated compounds 1 – 3 on  TSLP/TSLPR  interaction.

Journal: Molecules

Article Title: Lignans from Machilus thunbergii as Thymic Stromal Lymphopoietin Inhibitors

doi: 10.3390/molecules26164804

Figure Lengend Snippet: Molecular docking results of isolated compounds 1 – 3 on TSLP/TSLPR interaction.

Article Snippet: For the pSTAT5 assay measuring TSLP inhibitory activity, recombinant human TSLP was purchased from R&D Systems (Minneapolis, MN, USA) and BD Cytofix/Cytoperm and Alexa Fluor 647 mouse anti-STAT5 (pY694) were purchased from BD Biosciences (San Diego, CA, USA).

Techniques: Isolation

Molecular docking results of isolated compounds 1 – 3 against human TSLP in complex with TSLPR and interleukin-7 receptor α chain (IL-7Rα): ( A ) three-dimensional (3D) docking image of compound 1 ; ( B ) two-dimensional (2D) docking image of compound 1 ; ( C ) 3D docking image of compound 2 ; ( D ) 2D image picture of compound 2 ; ( E ) 3D docking image of compound 3 ; ( F ) 2D docking picture of compound 3 .

Journal: Molecules

Article Title: Lignans from Machilus thunbergii as Thymic Stromal Lymphopoietin Inhibitors

doi: 10.3390/molecules26164804

Figure Lengend Snippet: Molecular docking results of isolated compounds 1 – 3 against human TSLP in complex with TSLPR and interleukin-7 receptor α chain (IL-7Rα): ( A ) three-dimensional (3D) docking image of compound 1 ; ( B ) two-dimensional (2D) docking image of compound 1 ; ( C ) 3D docking image of compound 2 ; ( D ) 2D image picture of compound 2 ; ( E ) 3D docking image of compound 3 ; ( F ) 2D docking picture of compound 3 .

Article Snippet: For the pSTAT5 assay measuring TSLP inhibitory activity, recombinant human TSLP was purchased from R&D Systems (Minneapolis, MN, USA) and BD Cytofix/Cytoperm and Alexa Fluor 647 mouse anti-STAT5 (pY694) were purchased from BD Biosciences (San Diego, CA, USA).

Techniques: Isolation

Journal: iScience

Article Title: Immunometabolic adaptation in monocytes underpins functional changes during pregnancy

doi: 10.1016/j.isci.2024.109779

Figure Lengend Snippet:

Article Snippet: CD163 human antibody (clone GHI/61.1) , Miltenyi , Cat#130-123-249; RRID: AB_2819455.

Techniques: Recombinant, Adhesive, Sequencing, Modification, DC Protein Assay, Staining, Imaging, Enzyme-linked Immunosorbent Assay, Bicinchoninic Acid Protein Assay, Gene Expression, Software, Saline

Inflammation was assessed in DSS-treated Tslp-/- mice by (A) macroscopic disease, (B) colon length, (C) serum SAA concentration, (D&E) histological damage, (F) weight loss, and (G) survival. Graphs indicate: control (open bars), DSS (solid bars), mean ± SD, n=10-15 mice/group, scale bar=50μm, *P<0.05, ANOVA.

Journal: Immunity

Article Title: Thymic stromal lymphopoetin-induced expression of the endogenous inhibitory enzyme SLPI mediates recovery from colonic inflammation

doi: 10.1016/j.immuni.2011.05.015

Figure Lengend Snippet: Inflammation was assessed in DSS-treated Tslp-/- mice by (A) macroscopic disease, (B) colon length, (C) serum SAA concentration, (D&E) histological damage, (F) weight loss, and (G) survival. Graphs indicate: control (open bars), DSS (solid bars), mean ± SD, n=10-15 mice/group, scale bar=50μm, *P<0.05, ANOVA.

Article Snippet: Cells were stimulated with recombinant mouse TSLP (R&D systems).

Techniques: Concentration Assay, Control

FACS sorted CD4+CD45RBhi (Teff) ± CD4+CD45RBlo from Crlf2+/+ or Crlf2-/- were transferred to Rag1-/- recipients and monitored for (A) weight loss, (B) macroscopic disease, (C) colon length, and (D&E) histological damage (n=4-5 mice/group). (F) STAT5 phosphorylation was assessed following stimulation with rmIL-7 in CD4+ or CD8+ T-cells from Crlf2-/-, Tslp-/-, or WT (n=3 mice). (mean ± SD, scale bar =50μm)

Journal: Immunity

Article Title: Thymic stromal lymphopoetin-induced expression of the endogenous inhibitory enzyme SLPI mediates recovery from colonic inflammation

doi: 10.1016/j.immuni.2011.05.015

Figure Lengend Snippet: FACS sorted CD4+CD45RBhi (Teff) ± CD4+CD45RBlo from Crlf2+/+ or Crlf2-/- were transferred to Rag1-/- recipients and monitored for (A) weight loss, (B) macroscopic disease, (C) colon length, and (D&E) histological damage (n=4-5 mice/group). (F) STAT5 phosphorylation was assessed following stimulation with rmIL-7 in CD4+ or CD8+ T-cells from Crlf2-/-, Tslp-/-, or WT (n=3 mice). (mean ± SD, scale bar =50μm)

Article Snippet: Cells were stimulated with recombinant mouse TSLP (R&D systems).

Techniques: Phospho-proteomics

(A) Gene expression in colonic tissue was assessed by qRT-PCR (mean ± SD, n=10-15 mice/group, , control (open bars), DSS (solid bars), *P<0.05, ANOVA). (B) Mason's trichrome staining for collagen (blue) on colonic tissues from control and DSS-treated Tslp+/+ and Tslp-/- mice. (20× magnification is from red rectangle, 6 mice/group, scale bars=50μm). (C) SLPI expression was determined by immunoblotting colonic homogenates (n=6 mice/group). (D) MMP and (E) NE activity in colonic homogenates was assessed by a substrate cleavage assay (mean ± SD, n=4-9 mice/group, control (open symbols), DSS (solid symbols) *P<0.05 by ANOVA). (F) PGRN was determined in colonic homogenates by immunobloting (n=6 mice/group).

Journal: Immunity

Article Title: Thymic stromal lymphopoetin-induced expression of the endogenous inhibitory enzyme SLPI mediates recovery from colonic inflammation

doi: 10.1016/j.immuni.2011.05.015

Figure Lengend Snippet: (A) Gene expression in colonic tissue was assessed by qRT-PCR (mean ± SD, n=10-15 mice/group, , control (open bars), DSS (solid bars), *P<0.05, ANOVA). (B) Mason's trichrome staining for collagen (blue) on colonic tissues from control and DSS-treated Tslp+/+ and Tslp-/- mice. (20× magnification is from red rectangle, 6 mice/group, scale bars=50μm). (C) SLPI expression was determined by immunoblotting colonic homogenates (n=6 mice/group). (D) MMP and (E) NE activity in colonic homogenates was assessed by a substrate cleavage assay (mean ± SD, n=4-9 mice/group, control (open symbols), DSS (solid symbols) *P<0.05 by ANOVA). (F) PGRN was determined in colonic homogenates by immunobloting (n=6 mice/group).

Article Snippet: Cells were stimulated with recombinant mouse TSLP (R&D systems).

Techniques: Gene Expression, Quantitative RT-PCR, Control, Staining, Expressing, Western Blot, Activity Assay, Cleavage Assay

DSS-treated Tslp-/- or WT mice were gavaged with the NE inhibitor SSR69071 (3mg/kg) or vehicle (A) from day 6-14 and monitored for; (upper panel) weight loss, and (lower panel) mortality. In separate experiments, mice were gavaged with rSLPI (B) and assessed for (upper panel) weight loss, and (lower panel) mortality. (C&E) IEC proliferation as determined by colonic Ki67 staining after 4 days of treatment (day 10 post-DSS) with vehicle or SSR69071, and (D) apoptosis in Tslp+/+ and Tslp-/- DSS-treated mice. (F) Colonic PGRN was determined on full thickness tissue homogenates 10 days post-DSS. (mean ± SD, n=4 mice/group, *P<0.05, ANOVA).

Journal: Immunity

Article Title: Thymic stromal lymphopoetin-induced expression of the endogenous inhibitory enzyme SLPI mediates recovery from colonic inflammation

doi: 10.1016/j.immuni.2011.05.015

Figure Lengend Snippet: DSS-treated Tslp-/- or WT mice were gavaged with the NE inhibitor SSR69071 (3mg/kg) or vehicle (A) from day 6-14 and monitored for; (upper panel) weight loss, and (lower panel) mortality. In separate experiments, mice were gavaged with rSLPI (B) and assessed for (upper panel) weight loss, and (lower panel) mortality. (C&E) IEC proliferation as determined by colonic Ki67 staining after 4 days of treatment (day 10 post-DSS) with vehicle or SSR69071, and (D) apoptosis in Tslp+/+ and Tslp-/- DSS-treated mice. (F) Colonic PGRN was determined on full thickness tissue homogenates 10 days post-DSS. (mean ± SD, n=4 mice/group, *P<0.05, ANOVA).

Article Snippet: Cells were stimulated with recombinant mouse TSLP (R&D systems).

Techniques: Staining

(A) Confocal microscopy was performed for TSLP (blue), SLPI (red) and E-cadherin+ IEC (green) in Tslp+/+ mice (*, upper panels) and Tslp-/- mice (†, lower panels), (arrows, “L”=lumen, scale bars=20μm). WT mice reconstituted with Crlf2+/+ or Tslp-/- BM were subjected to colitis and assessed by (B) weight loss (C) colon length (D) Mason's trichrome staining (E) histological damage (F) and SLPI expression (mean ± SD, scale bar=100μm, n=3-4 mice/group, control (open bars), DSS (solid bars), *P<0.05, **P<0.001, ANOVA).

Journal: Immunity

Article Title: Thymic stromal lymphopoetin-induced expression of the endogenous inhibitory enzyme SLPI mediates recovery from colonic inflammation

doi: 10.1016/j.immuni.2011.05.015

Figure Lengend Snippet: (A) Confocal microscopy was performed for TSLP (blue), SLPI (red) and E-cadherin+ IEC (green) in Tslp+/+ mice (*, upper panels) and Tslp-/- mice (†, lower panels), (arrows, “L”=lumen, scale bars=20μm). WT mice reconstituted with Crlf2+/+ or Tslp-/- BM were subjected to colitis and assessed by (B) weight loss (C) colon length (D) Mason's trichrome staining (E) histological damage (F) and SLPI expression (mean ± SD, scale bar=100μm, n=3-4 mice/group, control (open bars), DSS (solid bars), *P<0.05, **P<0.001, ANOVA).

Article Snippet: Cells were stimulated with recombinant mouse TSLP (R&D systems).

Techniques: Confocal Microscopy, Mouse Assay, Staining, Expressing, Control

(A) Primary IEC were stained for flow cytometry for epithelial markers (E-cadherin+ CD3-, B220-, F4/80-) and TSLPR. (B) IHC was performed on colonic tissue sections with anti-TSLPR antibody. (C) TSLPR expression was assessed on fibroblasts (Vimentin+, alpha-smooth muscle actin- (α-SMA), E-cadherin- CD3- CD11b- B220- F4/80-) or myofibroblasts (Vimentin+ α-SMA+, E-cadherin- CD3- CD11b- B220- F4/80-) from Crlf2+/+ (grey fill black outline), and Crlf2-/- (negative control, red line) mice. (D) ERK and AKT phosphorylation in primary IEC from Crlf2+/+ and Crlf2-/- mice were assessed following stimulation with rmTSLP (50ng/mL, 30 min, mean ± SD, *P<0.05, ANOVA). (E) AKT Foxo3A and ERK phosphorylation were assessed in mICc12 cells by immunoblotting following stimulation with rmTSLP for the indicated times (50ng/mL). (F) Expression of anti-apoptotic genes including the Foxo3a regulated BCL2, and SLPI were determined following exposure to rmTSLP. (G) SLPI mRNA in mICcl2 cells following TSLP exposure was determined by qRT-PCR (n=3, mean ± SD, *P<0.05, ANOVA).

Journal: Immunity

Article Title: Thymic stromal lymphopoetin-induced expression of the endogenous inhibitory enzyme SLPI mediates recovery from colonic inflammation

doi: 10.1016/j.immuni.2011.05.015

Figure Lengend Snippet: (A) Primary IEC were stained for flow cytometry for epithelial markers (E-cadherin+ CD3-, B220-, F4/80-) and TSLPR. (B) IHC was performed on colonic tissue sections with anti-TSLPR antibody. (C) TSLPR expression was assessed on fibroblasts (Vimentin+, alpha-smooth muscle actin- (α-SMA), E-cadherin- CD3- CD11b- B220- F4/80-) or myofibroblasts (Vimentin+ α-SMA+, E-cadherin- CD3- CD11b- B220- F4/80-) from Crlf2+/+ (grey fill black outline), and Crlf2-/- (negative control, red line) mice. (D) ERK and AKT phosphorylation in primary IEC from Crlf2+/+ and Crlf2-/- mice were assessed following stimulation with rmTSLP (50ng/mL, 30 min, mean ± SD, *P<0.05, ANOVA). (E) AKT Foxo3A and ERK phosphorylation were assessed in mICc12 cells by immunoblotting following stimulation with rmTSLP for the indicated times (50ng/mL). (F) Expression of anti-apoptotic genes including the Foxo3a regulated BCL2, and SLPI were determined following exposure to rmTSLP. (G) SLPI mRNA in mICcl2 cells following TSLP exposure was determined by qRT-PCR (n=3, mean ± SD, *P<0.05, ANOVA).

Article Snippet: Cells were stimulated with recombinant mouse TSLP (R&D systems).

Techniques: Staining, Flow Cytometry, Expressing, Negative Control, Phospho-proteomics, Western Blot, Quantitative RT-PCR

Figure 1. CRLF2 mRNA and TSLP protein are elevated in patient endometriotic lesions compared with control endometrial samples. RT-qPCR was run with RNA extracted from control endometria (n ¼ 7), patient eutopic endometria (n ¼ 5), and endometriotic lesions (n ¼ 8). The expression of (A) TSLP, (B) CRLF2, and (C) IL-7R was quantified relative to the GAPDH reference gene. A TMA with (D) control endometrial tissue (n ¼ 15) and matched (E) patient (n ¼ 15) eutopic endometria and (F) endometriotic lesions was stained with anti-TSLP Ab. TSLP-positive (G) stromal and (H) epithelial area was calculated as a fraction of total stromal and epithelial area, respectively, using HALO AI. Magnification provided at 8×. Scale bars ¼ 100 μm. A 1-way analysis of variance with Tukey post hoc test was used to assess statistical significance. P < 0.05, P < 0.01.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Article Title: Thymic stromal lymphopoietin contributes to endometriotic lesion proliferation and disease-associated inflammation.

doi: 10.1093/jimmun/vkae021

Figure Lengend Snippet: Figure 1. CRLF2 mRNA and TSLP protein are elevated in patient endometriotic lesions compared with control endometrial samples. RT-qPCR was run with RNA extracted from control endometria (n ¼ 7), patient eutopic endometria (n ¼ 5), and endometriotic lesions (n ¼ 8). The expression of (A) TSLP, (B) CRLF2, and (C) IL-7R was quantified relative to the GAPDH reference gene. A TMA with (D) control endometrial tissue (n ¼ 15) and matched (E) patient (n ¼ 15) eutopic endometria and (F) endometriotic lesions was stained with anti-TSLP Ab. TSLP-positive (G) stromal and (H) epithelial area was calculated as a fraction of total stromal and epithelial area, respectively, using HALO AI. Magnification provided at 8×. Scale bars ¼ 100 μm. A 1-way analysis of variance with Tukey post hoc test was used to assess statistical significance. P < 0.05, P < 0.01.

Article Snippet: Cells were treated in triplicates with vehicle control (PBS) or various concentrations of recombinant mouse TSLP (rmTSLP) (555-TS-010/CF; R&D Systems; 1, 10, 50 ng/mL) for 7 d at 37 �C with 5% CO2.

Techniques: Control, Quantitative RT-PCR, Expressing, Staining

Figure 2. TSLP treatment alters the proliferation and apoptosis of human endometriosis-representative cell lines. (A, B) 12Zs, (C, D) hESCs, and (E, F) THP-1 cells were treated with vehicle control (PBS) or various concentrations of rhTSLP (1, 10, 50 ng/mL) for 24 h. (A, C, E) WST-I proliferation and (B, D, F) caspase-3/7 apoptosis assays were performed. A 1-way analysis of variance with Tukey post hoc test was used to assess statistical significance. P < 0.05, P < 0.01, P < 0.001, P < 0.0001.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Article Title: Thymic stromal lymphopoietin contributes to endometriotic lesion proliferation and disease-associated inflammation.

doi: 10.1093/jimmun/vkae021

Figure Lengend Snippet: Figure 2. TSLP treatment alters the proliferation and apoptosis of human endometriosis-representative cell lines. (A, B) 12Zs, (C, D) hESCs, and (E, F) THP-1 cells were treated with vehicle control (PBS) or various concentrations of rhTSLP (1, 10, 50 ng/mL) for 24 h. (A, C, E) WST-I proliferation and (B, D, F) caspase-3/7 apoptosis assays were performed. A 1-way analysis of variance with Tukey post hoc test was used to assess statistical significance. P < 0.05, P < 0.01, P < 0.001, P < 0.0001.

Article Snippet: Cells were treated in triplicates with vehicle control (PBS) or various concentrations of recombinant mouse TSLP (rmTSLP) (555-TS-010/CF; R&D Systems; 1, 10, 50 ng/mL) for 7 d at 37 �C with 5% CO2.

Techniques: Control

Figure 3. TSLP treatment influences the polarization of THP-1 cells and mouse BMDMs. THP-1 cells were treated with vehicle control (PBS) or various concentrations of rhTSLP (1, 10, 50 ng/mL) for 1 d, and mouse BMDMs were treated with vehicle control (PBS) or various concentrations of rmTSLP (1, 10, 50 ng/mL) for 7 d. (A) Flow cytometry was used to detect the expression of (B) CD11b, (C) CD163, and CD86 on THP-1 cells, as well as (D) CD11b, F4/80, (E) CD80, and CD206 on BMDMs. Quantification of results is provided in Figs. S2 and S3. Cell supernatant was collected from BMDMs and analyzed to detect the expression of several inflammation- and angiogenesis-related cytokines and chemokines, including (F) MCP-1, (G) IP-10, and (H) MIP-1α. A 1-way analysis of variance with Tukey post hoc test was conducted to assess statistical significance. P < 0.05, P < 0.01, P < 0.001.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Article Title: Thymic stromal lymphopoietin contributes to endometriotic lesion proliferation and disease-associated inflammation.

doi: 10.1093/jimmun/vkae021

Figure Lengend Snippet: Figure 3. TSLP treatment influences the polarization of THP-1 cells and mouse BMDMs. THP-1 cells were treated with vehicle control (PBS) or various concentrations of rhTSLP (1, 10, 50 ng/mL) for 1 d, and mouse BMDMs were treated with vehicle control (PBS) or various concentrations of rmTSLP (1, 10, 50 ng/mL) for 7 d. (A) Flow cytometry was used to detect the expression of (B) CD11b, (C) CD163, and CD86 on THP-1 cells, as well as (D) CD11b, F4/80, (E) CD80, and CD206 on BMDMs. Quantification of results is provided in Figs. S2 and S3. Cell supernatant was collected from BMDMs and analyzed to detect the expression of several inflammation- and angiogenesis-related cytokines and chemokines, including (F) MCP-1, (G) IP-10, and (H) MIP-1α. A 1-way analysis of variance with Tukey post hoc test was conducted to assess statistical significance. P < 0.05, P < 0.01, P < 0.001.

Article Snippet: Cells were treated in triplicates with vehicle control (PBS) or various concentrations of recombinant mouse TSLP (rmTSLP) (555-TS-010/CF; R&D Systems; 1, 10, 50 ng/mL) for 7 d at 37 �C with 5% CO2.

Techniques: Control, Flow Cytometry, Expressing

Figure 4. TSLP treatment influences the presence and activation of immune cells in the peritoneal fluid of mice induced with endometriosis. Mice were treated with intraperitoneal PBS (n ¼ 5) or rmTSLP (2 μg or 0.01 mg/kg; n ¼ 4) every other day for 14 d. (A–E) Myeloid and (F–J) lymphoid cells, as well as their (B, D, G, J) TSLPR expression, (E) IRF4 expression, and (F, J) IRF-4/T-bet ratio was measured. Quantification of results is provided in Fig. S4. An unpaired Student’s t test was used to assess statistical significance. P < 0.05, P < 0.01, P < 0.001.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Article Title: Thymic stromal lymphopoietin contributes to endometriotic lesion proliferation and disease-associated inflammation.

doi: 10.1093/jimmun/vkae021

Figure Lengend Snippet: Figure 4. TSLP treatment influences the presence and activation of immune cells in the peritoneal fluid of mice induced with endometriosis. Mice were treated with intraperitoneal PBS (n ¼ 5) or rmTSLP (2 μg or 0.01 mg/kg; n ¼ 4) every other day for 14 d. (A–E) Myeloid and (F–J) lymphoid cells, as well as their (B, D, G, J) TSLPR expression, (E) IRF4 expression, and (F, J) IRF-4/T-bet ratio was measured. Quantification of results is provided in Fig. S4. An unpaired Student’s t test was used to assess statistical significance. P < 0.05, P < 0.01, P < 0.001.

Article Snippet: Cells were treated in triplicates with vehicle control (PBS) or various concentrations of recombinant mouse TSLP (rmTSLP) (555-TS-010/CF; R&D Systems; 1, 10, 50 ng/mL) for 7 d at 37 �C with 5% CO2.

Techniques: Activation Assay, Expressing

Figure 6. TSLP treatment reduces the concentrations of prevalent proinflammatory cytokines in mouse peritoneal fluid. Mice were treated with intraperitoneal PBS (n ¼ 5) or rmTSLP (2 μg or 0.01 mg/kg; n ¼ 4) every other day for 14 d. Peritoneal fluid was collected to detect predominant inflammatory cytokines and chemokines. Key (A, B) proinflammatory and (C, D) anti-inflammatory cytokines are shown. An unpaired Student’s t test was conducted to assess statistical significance. P < 0.05.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Article Title: Thymic stromal lymphopoietin contributes to endometriotic lesion proliferation and disease-associated inflammation.

doi: 10.1093/jimmun/vkae021

Figure Lengend Snippet: Figure 6. TSLP treatment reduces the concentrations of prevalent proinflammatory cytokines in mouse peritoneal fluid. Mice were treated with intraperitoneal PBS (n ¼ 5) or rmTSLP (2 μg or 0.01 mg/kg; n ¼ 4) every other day for 14 d. Peritoneal fluid was collected to detect predominant inflammatory cytokines and chemokines. Key (A, B) proinflammatory and (C, D) anti-inflammatory cytokines are shown. An unpaired Student’s t test was conducted to assess statistical significance. P < 0.05.

Article Snippet: Cells were treated in triplicates with vehicle control (PBS) or various concentrations of recombinant mouse TSLP (rmTSLP) (555-TS-010/CF; R&D Systems; 1, 10, 50 ng/mL) for 7 d at 37 �C with 5% CO2.

Techniques:

Figure 5. TSLP treatment influences the presence and activation of immune cells in circulation. Mice were treated with intraperitoneal PBS (n ¼ 5) or rmTSLP (2 μg or 0.01 mg/kg; n ¼ 4) every other day for 14 d. (A–C) Myeloid and (D–H) lymphoid cells and their (B, E, H) TSLPR expression, (C) IRF-4 expression, and (F, J) IRF-4/T-BET ratio were measured. Quantification of results is provided in Fig. S4. An unpaired Student’s t test was used to assess statistical significance. P < 0.05, P < 0.01, P < 0.001.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Article Title: Thymic stromal lymphopoietin contributes to endometriotic lesion proliferation and disease-associated inflammation.

doi: 10.1093/jimmun/vkae021

Figure Lengend Snippet: Figure 5. TSLP treatment influences the presence and activation of immune cells in circulation. Mice were treated with intraperitoneal PBS (n ¼ 5) or rmTSLP (2 μg or 0.01 mg/kg; n ¼ 4) every other day for 14 d. (A–C) Myeloid and (D–H) lymphoid cells and their (B, E, H) TSLPR expression, (C) IRF-4 expression, and (F, J) IRF-4/T-BET ratio were measured. Quantification of results is provided in Fig. S4. An unpaired Student’s t test was used to assess statistical significance. P < 0.05, P < 0.01, P < 0.001.

Article Snippet: Cells were treated in triplicates with vehicle control (PBS) or various concentrations of recombinant mouse TSLP (rmTSLP) (555-TS-010/CF; R&D Systems; 1, 10, 50 ng/mL) for 7 d at 37 �C with 5% CO2.

Techniques: Activation Assay, Expressing

Figure 7. TSLP treatment significantly increases the presence of TSLP within endometriotic lesions and lesion proliferation. Endometriotic lesions from mice treated with intraperitoneal PBS (n¼ 5) or rmTSLP (2μg or 0.01mg/kg; n¼ 4) were embedded in paraffin and stained with (A, B) anti-TSLP, (C, D) anti-TSLPR, (E, F) anti-Ki67, and (G, H) anti-CD31 Abs. (I) TSLP-positive, (J) TSLPR-positive, (K) Ki67-positive, and (L) CD31-positive tissue was calculated with HALO AI. Magnification provided at 20×. Scale bars ¼ 50μm. An unpaired Student’s t test was used to assess statistical significance. P< 0.05, P< 0.001.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Article Title: Thymic stromal lymphopoietin contributes to endometriotic lesion proliferation and disease-associated inflammation.

doi: 10.1093/jimmun/vkae021

Figure Lengend Snippet: Figure 7. TSLP treatment significantly increases the presence of TSLP within endometriotic lesions and lesion proliferation. Endometriotic lesions from mice treated with intraperitoneal PBS (n¼ 5) or rmTSLP (2μg or 0.01mg/kg; n¼ 4) were embedded in paraffin and stained with (A, B) anti-TSLP, (C, D) anti-TSLPR, (E, F) anti-Ki67, and (G, H) anti-CD31 Abs. (I) TSLP-positive, (J) TSLPR-positive, (K) Ki67-positive, and (L) CD31-positive tissue was calculated with HALO AI. Magnification provided at 20×. Scale bars ¼ 50μm. An unpaired Student’s t test was used to assess statistical significance. P< 0.05, P< 0.001.

Article Snippet: Cells were treated in triplicates with vehicle control (PBS) or various concentrations of recombinant mouse TSLP (rmTSLP) (555-TS-010/CF; R&D Systems; 1, 10, 50 ng/mL) for 7 d at 37 �C with 5% CO2.

Techniques: Staining